Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2024 | 09-2023 | 09-2022 | 09-2021 | 09-2020 | |
| Operating Expenses | 3,558 | 2,996 | 1,080 | 892 | 4,458 |
| Operating Income | -3,558 | -2,996 | -1,080 | -892 | -4,458 |
| Interest Expense | 389 | 359 | 309 | 273 | 176 |
| Other Income | 27 | 28 | 0 | -5 | 5 |
| Pre-tax Income | -3,920 | -3,327 | -1,389 | -1,170 | -4,629 |
| Net Income Continuous | -3,920 | -3,327 | -1,389 | -1,170 | -4,629 |
| Net Income | $-3,920 | $-3,327 | $-1,389 | $-1,170 | $-4,629 |
| EPS Basic Total Ops | -0.06 | -0.05 | -0.02 | -0.02 | -0.08 |
| EPS Basic Continuous Ops | -0.06 | -0.05 | -0.02 | -0.02 | -0.08 |
| EPS Diluted Total Ops | -0.06 | -0.05 | -0.02 | -0.02 | -0.08 |
| EPS Diluted Continuous Ops | -0.06 | -0.05 | -0.02 | -0.02 | -0.08 |
| EBITDA(a) | $-3,531 | $-2,968 | $-1,080 | $-896 | $-4,453 |